Read More Medical Neoadjuvant Chemotherapy Reduces Colon Cancer Recurrence Rate By 28%, With Fewer Post-Operative Complications, Study Shows Nov 15, 2024
Read More Apparatus Heavyweight! First ADC Drug For Refractory Ovarian Cancer Receives Accelerated FDA Approval Nov 03, 2024
Read More Apparatus New Findings Confirm: Excellent Data On This Bipotent Antibody Drug Against Ovarian Cancer! Nov 23, 2024
Read More Apparatus Significantly Longer Survival In Refractory Breast Cancer With The Addition Of Eganelisib To Standard Treatment! Nov 06, 2024
